Identification of novel mutations in

Novel mutations SLC19A3 TPK1 Thiamine metabolism dysfunction syndrome Whole-exome sequencing (WES)

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Mar 2024
Historique:
received: 04 07 2023
revised: 10 12 2023
accepted: 28 02 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

The occurrence of thiamine metabolism dysfunction syndrome (THMD), a rare autosomal recessive condition, may be linked to various mutations found in the The selection of cases for this study was based on the phenotypic and genetic information that was obtainable from the Center for Comprehensive Genetic Services. The genetic basis for the problems observed among the participants was determined through the application of whole-exome sequencing (WES). Subsequently, sanger sequencing was employed as a means of validating any identified variations suspected to be causative. The first patient exhibited a homozygous mutation in the Collectively, when presented with patients showcasing ataxia, encephalopathy, and basal ganglia necrosis, it is essential to account for thiamine deficiency in light of the potential advantages of prompt intervention. At times, it may be feasible to rectify this deficiency through the timely administration of thiamine dosages. Accordingly, based on the results of the current investigation, these variations may be useful for the diagnosis and management of patients with THMD.

Sections du résumé

Background and aims UNASSIGNED
The occurrence of thiamine metabolism dysfunction syndrome (THMD), a rare autosomal recessive condition, may be linked to various mutations found in the
Material and methods UNASSIGNED
The selection of cases for this study was based on the phenotypic and genetic information that was obtainable from the Center for Comprehensive Genetic Services. The genetic basis for the problems observed among the participants was determined through the application of whole-exome sequencing (WES). Subsequently, sanger sequencing was employed as a means of validating any identified variations suspected to be causative.
Results UNASSIGNED
The first patient exhibited a homozygous mutation in the
Conclusions UNASSIGNED
Collectively, when presented with patients showcasing ataxia, encephalopathy, and basal ganglia necrosis, it is essential to account for thiamine deficiency in light of the potential advantages of prompt intervention. At times, it may be feasible to rectify this deficiency through the timely administration of thiamine dosages. Accordingly, based on the results of the current investigation, these variations may be useful for the diagnosis and management of patients with THMD.

Identifiants

pubmed: 38501011
doi: 10.1016/j.heliyon.2024.e27434
pii: S2405-8440(24)03465-0
pmc: PMC10945192
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27434

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.

Auteurs

Fatemeh Norouzi Rostami (F)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Hossein Sadeghi (H)

Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farzad Hashemi-Gorji (F)

Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Sahand Tehrani Fateh (S)

School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Reza Mirfakhraie (R)

Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Parvaneh Karimzadeh (P)

Department of Pediatric Neurology, School of Medicine, Pediatric Neurology Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Milad Davarpanah (M)

Students' Research Committee, Isfahan University of Medical Science, Isfahan, Iran.

Sanaz Jamshidi (S)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Rasoul Madannejad (R)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Parinaz Moghimi (P)

School of Medicine, Islamic Azad University Tehran Medical Sciences, Tehran, Iran.

Mahdis Ekrami (M)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Miryounesi (M)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad-Reza Ghasemi (MR)

Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH